查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲肉毒桿菌毒素市場預測至2031 年- 區域分析- 按產品（肉毒桿菌毒素A 和肉毒桿菌毒素B）、應用（醫療和美容）和最終用戶（專科和皮膚科診所、醫院和診所等）
市場調查報告書
商品編碼
1592660

歐洲肉毒桿菌毒素市場預測至2031 年- 區域分析- 按產品（肉毒桿菌毒素A 和肉毒桿菌毒素B）、應用（醫療和美容）和最終用戶（專科和皮膚科診所、醫院和診所等）

Europe Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), and End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others)
出版日期: | 出版商: The Insight Partners | 英文 75 Pages | 訂單完成後即時交付

價格

2023年歐洲肉毒桿菌毒素市值為11.7494億美元，預計到2031年將達到29.3174億美元；預計2023年至2031年複合年成長率為12.1%。

歐洲人口老化推動歐洲肉毒桿菌毒素市場

歐洲人口老化為市場成長提供了重大機會。隨著該地區的人口結構向老年人口傾斜，對肉毒桿菌等抗衰老治療的需求也隨之增加。隨著老年人尋求非侵入性解決方案來保持年輕的外表，對真皮填充劑的需求不斷增加。截至2023年1月1日，歐盟人口估計為4.488億，其中近五分之一（21.3%）的人口年齡在65歲或以上。 2023 年 1 月 1 日，歐盟人口的中位數年齡達到 44.5 歲。

歐洲肉毒毒素市場概況

歐洲肉毒桿菌市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。歐洲在全球肉毒桿菌毒素市場中佔據重要地位，預計在預測期內將錄得強勁成長率。該地區的市場成長主要歸因於肉毒毒素公司的產品開發以及德國、英國、法國和義大利等歐洲國家各個年齡層的人們對現代美容標準意識的高漲。此外，醫療保健系統的進步可能會在未來幾年推動整個地區對肉毒桿菌毒素的需求。德國醫療保健產業在美容和醫療程序中採用先進技術。根據 ISAPS 的數據，2021 年全國共進行了 605,942 例非手術美容手術，其中包括 306,296 例肉毒桿菌治療。因此，隨著非手術整容手術數量的增加以及微創手術意識的增強，德國的肉毒桿菌市場預計將會成長。此外，該公司正在該國推出產品以供直接訂單和客戶交付。 2023 年 2 月，Evolus, Inc. 在德國商業推出 Nuceiva，用於直接訂購和交付給客戶。

歐洲肉毒桿菌毒素市場收入及 2031 年預測（百萬美元）

歐洲肉毒桿菌毒素市場細分

歐洲肉毒桿菌毒素市場按產品、應用、最終用戶和國家分類。

根據產品，歐洲肉毒桿菌毒素市場分為肉毒桿菌毒素A和肉毒桿菌毒素B。

從應用來看，歐洲肉毒桿菌市場分為醫療和美容。到2023年，醫療領域在歐洲肉毒桿菌毒素市場中佔據較大佔有率。此外，美觀部分也細分為皺眉紋/眉間紋、額頭紋、魚尾紋、方下巴/咬肌等。

依最終用戶分類，歐洲肉毒桿菌市場分為專科和皮膚科診所、醫院和診所等。 2023 年，專科診所和皮膚科診所佔據歐洲肉毒桿菌市場的最大佔有率。

根據國家/地區，歐洲肉毒桿菌市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2023年，德國在歐洲肉毒桿菌毒素市場佔有率中佔據主導地位。

Merz Pharma GmbH & Co KGaA、AbbVie Inc、Ipsen SA、Evolus Inc、Meditox Inc 和 Galderma SA 是歐洲肉毒桿菌毒素市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲肉毒桿菌毒素市場 - 主要市場動態

  • 市場促進因素
    • 非侵入性美容手術日益普及
    • 增加肉毒桿菌毒素的使用以增強臉部美觀
  • 市場限制
    • 肉毒桿菌毒素的副作用
  • 市場機會
    • 人口老化
  • 未來趨勢
    • 擴大治療應用
  • 促進因素和限制的影響：

第 5 章：肉毒桿菌市場 - 歐洲分析

  • 概述
  • 肉毒桿菌市場收入，2021-2031

第 6 章：歐洲肉毒桿菌市場分析 - 按產品

  • 概述
  • A型肉毒桿菌毒素
  • 肉毒桿菌B

第 7 章：歐洲肉毒桿菌毒素市場分析 - 按應用

  • 概述
  • 醫療的
  • 美學的

第 8 章：歐洲肉毒桿菌毒素市場分析 - 按最終用戶

  • 概述
  • 專科和皮膚科診所
  • 醫院和診所
  • 其他

第 9 章：歐洲肉毒桿菌毒素市場 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 10 章：公司簡介

  • Merz Pharma GmbH & Co KGaA
  • AbbVie Inc
  • Ipsen SA
  • Evolus Inc
  • Medytox Inc
  • Galderma SA

第 11 章：附錄

Product Code: TIPRE00026638

The Europe botulinum toxin market was valued at US$ 1,174.94 million in 2023 and is expected to reach US$ 2,931.74 million by 2031; it is estimated to register a CAGR of 12.1% from 2023 to 2031 .

Aging Population in Europe Drives Europe Botulinum Toxin Market

The aging population in Europe presents a significant opportunity for market growth. As the region's demographic landscape shifts towards an older population, there is a parallel increase in demand for anti-aging treatments, such as botox. With older individuals seeking non-invasive solutions to maintain a youthful appearance, the demand for dermal fillers is increasing. As of January 1, 2023, the estimated population of the European Union was 448.8 million, with almost one-fifth (21.3%) of the population being 65 years of age or older. The EU's population reached a median age of 44.5 years on January 1, 2023. Advancements in filler technology that offer longer-lasting results and natural-looking outcomes cater to the preference of this demographic, further driving market expansion.

Europe Botulinum Toxin Market Overview

The Europe botulinum toxin market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global botulinum toxin market, and it is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to product developments by botulinum toxin companies and an upsurge in the awareness of modern beauty standards among people from all age groups in European countries such as Germany, the UK, France, and Italy. In addition, advancements in healthcare systems are likely to propel the demand for botulinum toxin across the region in the coming years. The German healthcare sector utilizes advanced technologies in aesthetic and medical procedures. According to the ISAPS, a total of 605,942 nonsurgical aesthetic procedures were performed in the country in 2021, including 306,296 botulinum toxin treatments. Thus, the botulinum toxin market in Germany is expected to grow with the rising number of nonsurgical cosmetic procedures, and the growing awareness of minimally invasive procedures. Also, companies are launching products in the country for direct orders and customer delivery. In February 2023, Evolus, Inc. commercially launched Nuceiva in Germany for direct orders and delivery to customers.

Europe Botulinum Toxin Market Revenue and Forecast to 2031 (US$ Million)

Europe Botulinum Toxin Market Segmentation

The Europe botulinum toxin market is categorized into product, application, end user, and country.

Based on product, the Europe botulinum toxin market is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger share of Europe botulinum toxin market share in 2023.

In terms of application, the Europe botulinum toxin market is bifurcated into medical and aesthetic. The medical segment held a larger share of Europe botulinum toxin market in 2023. Furthermore, the medical segment is subcategorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. Additionally, the aesthetic segment is subcategorized into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others.

By end user, the Europe botulinum toxin market is divided into specialty & dermatology clinics, hospitals & clinics, and others. The specialty and dermatology clinics segment held the largest share of Europe botulinum toxin market in 2023.

Based on country, the Europe botulinum toxin market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe botulinum toxin market share in 2023.

Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Evolus Inc, Medytox Inc, and Galderma SA are some of the leading companies operating in the Europe botulinum toxin market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Botulinum Toxin Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Popularity of Noninvasive Aesthetics Procedures
    • 4.1.2 Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
  • 4.2 Market Restraints
    • 4.2.1 Side Effects of Botulinum Toxin
  • 4.3 Market Opportunities
    • 4.3.1 Aging Population
  • 4.4 Future Trends
    • 4.4.1 Expanding Therapeutic Applications
  • 4.5 Impact of Drivers and Restraints:

5. Botulinum Toxin Market - Europe Analysis

  • 5.1 Overview
  • 5.2 Botulinum Toxin Market Revenue (US$ Million), 2021-2031

6. Europe Botulinum Toxin Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Botulinum Toxin A
    • 6.2.1 Overview
    • 6.2.2 Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Botulinum Toxin B
    • 6.3.1 Overview
    • 6.3.2 Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Botulinum Toxin Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Medical
    • 7.2.1 Overview
    • 7.2.2 Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.2.2.1 Europe Botulinum Toxin Market Breakdown, by Medical
  • 7.3 Aesthetic
    • 7.3.1 Overview
    • 7.3.2 Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.3.2.1 Europe Botulinum Toxin Market Breakdown, by Aesthetic

8. Europe Botulinum Toxin Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Specialty and Dermatology Clinics
    • 8.2.1 Overview
    • 8.2.2 Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Hospitals and Clinics
    • 8.3.1 Overview
    • 8.3.2 Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Botulinum Toxin Market - Country Analysis

  • 9.1 Europe: Botulinum Toxin Market
    • 9.1.1 Europe: Botulinum Toxin Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Germany
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.3 Germany: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.1.4 Germany: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.1.4.1 Germany: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.1.4.2 Germany: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.1.5 Germany: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.2 United Kingdom
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.3 United Kingdom: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.2.4 United Kingdom: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.2.4.1 United Kingdom: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.2.4.2 United Kingdom: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.2.5 United Kingdom: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.3 France
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.3 France: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.3.4 France: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.3.4.1 France: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.3.4.2 France: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.3.5 France: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.4 Italy
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.3 Italy: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.4.4 Italy: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.4.4.1 Italy: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.4.4.2 Italy: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.4.5 Italy: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.5 Spain
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.3 Spain: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.5.4 Spain: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.5.4.1 Spain: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.5.4.2 Spain: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.5.5 Spain: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.6 Rest of Europe
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.6.4 Rest of Europe: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.6.4.1 Rest of Europe: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.6.4.2 Rest of Europe: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.6.5 Rest of Europe: Botulinum Toxin Market Breakdown, by End User

10. Company Profiles

  • 10.1 Merz Pharma GmbH & Co KGaA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 AbbVie Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Ipsen SA
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Evolus Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Medytox Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Galderma SA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners

List Of Tables

  • Table 1. Botulinum Toxin Market Segmentation
  • Table 2. Europe Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 3. Europe Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 4. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 7. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 8. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 9. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 10. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 12. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 13. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 15. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 16. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 17. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 18. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 20. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 21. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 22. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 23. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 24. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 25. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 26. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 27. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 28. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 29. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 30. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 31. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 32. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 33. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Botulinum Toxin Market Segmentation, by Country
  • Figure 2. Botulinum Toxin Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2021-2031
  • Figure 5. Botulinum Toxin Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Botulinum Toxin Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Botulinum Toxin Market Share (%) - by End User (2023 and 2031)
  • Figure 12. Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Europe: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 16. Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 17. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)